This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
W.R. Berkley (WRB) Gains 33% in a Year: What's Driving It?
by Zacks Equity Research
W.R. Berkley (WRB) stock soars on the back of higher premiums, lower claims frequency in certain lines of business, effective capital deployment and sufficient liquidity.
Palomar Holdings (PLMR) Rises 43% in a Year: What's Driving It?
by Zacks Equity Research
Palomar Holdings (PLMR) gains from new business, strong retention rates, expansion of products??? geographic and distribution footprint, new partnerships and high-quality fixed-income securities.
5 Small-Cap Stocks to Buy Despite Inflation Headwinds
by Nalak Das
We have narrowed our search to five small-cap (market capital < $1 billion) stocks. These stocks are: AXL, EVER, GRC, ROOT, NVRI.
MetLife (MET) Arm MIM Secures $1.2B for 2nd Private Equity Fund
by Zacks Equity Research
MetLife (MET) Arm, MIM, plans to utilize $250 million on new private equity opportunities.
Marsh & McLennan (MMC) Units Bolster Portfolio With Key Buyouts
by Zacks Equity Research
The acquisitions of AmeriStar Agency, Hudson Shore Group and Veritas Total Solutions are set to bolster Marsh & McLennan's (MMC) growth, expertise and competitive edge in diverse sectors.
Aegon (AEG) Wraps Up EUR 1.535B Planned Share Repurchase
by Zacks Equity Research
Aegon (AEG) has a new repurchase program of EUR 200 million, which was expected to start from this month and complete by 2024-end.
Here's Why You Should Hold RenaissanceRe (RNR) Stock for Now
by Zacks Equity Research
RenaissanceRe (RNR) is expected to benefit from rising premiums, net investment income, and underwriting capabilities.
5 Property & Casualty Insurers to Buy for Sparkling Returns
by Nalak Das
We have narrowed our search to five P&C insurers with strong potential for the rest of 2024. These stocks are: HCI, RLI, PLMR, PRA, ROOT.
MetLife (MET), Micruity Unite to Enhance Retirement Solutions
by Zacks Equity Research
MetLife (MET) expands collaboration with Micruity in a bid to develop MetLife's Universal Digital Platform and enhance access to retirement solutions.
Here's Why You Should Hold Marsh & McLennan (MMC) Stock Now
by Zacks Equity Research
Marsh & McLennan (MMC) is well-poised for growth on the back of rising demand for services, revenue growth and margin expansion outlook.
Here's Why Investors Should Retain AON Stock in Their Portfolio
by Zacks Equity Research
AON's Health Solutions segment is expected to witness 5.7% organic revenue growth in 2024, exceeding $2.8 billion in total.
Marsh & McLennan (MMC) to Enhance Wealth Unit With Acquisition
by Zacks Equity Research
Marsh & McLennan (MMC) agrees to acquire Cardano in a bid to expand its offerings in the UK and the Netherlands.
AON Leads $350M Insurance Initiative for Ukraine Recovery
by Zacks Equity Research
The move from AON and its partners is expected to provide protection for capital, which is likely to aid investments in the country.
AIG Reaches Key Milestone With Deconsolidation of Corebridge
by Zacks Equity Research
AIG now owns around 48.35% of Corebridge's common stock.
MetLife (MET) Explores Acquisition of Hayfin Capital Management (revised)
by Zacks Equity Research
MetLife (MET) is in talks to consider the Hayfin Capital Management acquisition, expanding its presence in the private capital market.
ProAssurance (PRA) Rises 8.5% in 3 Months: More Growth Ahead?
by Zacks Equity Research
Thanks to its cost-controlling efforts, ProAssurance's (PRA) expenses are expected to decline in the coming quarters.
MetLife (MET) Explores Acquisition of Hayfin Capital Management
by Zacks Equity Research
MetLife (MET) is in talks to consider the Hayfin Capital Management acquisition, expanding its presence in the private capital market.
Marsh & McLennan (MMC) Arm Buys Perkins Insurance in West Texas
by Zacks Equity Research
The acquisition is expected to boost Marsh & McLennan's (MMC) footprint in the West Texas market and enhance its service offerings.
AIG to Sell 30M Corebridge Shares Through Secondary Offering
by Zacks Equity Research
AIG revealed the pricing for the secondary offering for CRBG common stock at $29.20 per share.
MetLife's (MET) My Leave Navigator to Boost Leave Experience
by Zacks Equity Research
MetLife (MET) is introducing tailored products according to the market demand, enabling better market penetration and generating steady premiums.
Why You Should Retain Marsh & McLennan (MMC) Stock for Now
by Zacks Equity Research
Marsh & McLennan's (MMC) is well-poised for growth on the back of increasing demand for services, revenue growth and margin expansion outlook.
Aflac (AFL) to Acquire 40% Stake in Tree Line Capital for $100M
by Zacks Equity Research
Aflac (AFL) is now poised to reap the rewards of high returns from private credits.
AIG to Divest 20% Corebridge Stake to Nippon Life for $3.8B
by Zacks Equity Research
AIG continues to streamline its operations to intensify focus on its General Insurance business.
Are You Looking for a Top Momentum Pick? Why Root, Inc. (ROOT) is a Great Choice
by Zacks Equity Research
Does Root, Inc. (ROOT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Root, Inc. (ROOT) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?